டெர்ரி சாலயேற் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from டெர்ரி சாலயேற். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In டெர்ரி சாலயேற் Today - Breaking & Trending Today
InDevR Launches VaxArray Polio Kit for Faster, Multiplexed Vaccine Characterization prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
InDevR Launches VaxArray Measles and Rubella Kit for Improved Vaccine Antigen Characterization USA - English Share this article Share this article BOULDER, Colorado, Jan. 19, 2021 /PRNewswire/ InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray ® Measles and Rubella (MR) antigen quantification kit. Funded by the Bill and Melinda Gates Foundation with the goal of reducing the time and cost of manufacturing for these life-saving vaccines, InDevR s VaxArray MR kit leverages the company s established VaxArray ® platform to deliver a rapid quantitative analysis of specific measles and rubella antigens. The VaxArray MR kit provides a precise measure of antigen content in 5 hours, which is a fraction of the time needed for the traditional 10-14-day tissue culture infectious dose measurement. The ....
InDevR Expands Commercial Portfolio for Coronavirus Vaccine Characterization USA - English Share this article Share this article BOULDER, Colo., Dec. 10, 2020 /PRNewswire/ InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Spike Protein Kit and SARS-CoV-2 Spike Protein Standard for vaccine antigen quantification. Of the many coronavirus vaccine candidates in development, several are based on either whole virus or recombinant spike-protein. Quantification of the spike protein concentration, or potency, at various steps in the manufacturing process is critical for characterizing vaccine performance. Many developers rely on in-house immunoassays for early protein quantification work. To streamline vaccine development, InDevR offers an off-the-shelf VaxArray kit for multiplexed quantification of sp ....